Skip to main content Accessibility help
×
Home

Attention/Working Memory, Learning and Memory in Adult Cameroonians: Normative Data, Effects of HIV Infection and Viral Genotype

  • Georgette D. Kanmogne (a1), Julius Y. Fonsah (a2) (a3), Anya Umlauf (a4), Jacob Moul (a4), Roland F. Doh (a3), Anne M. Kengne (a3), Bin Tang (a4), Claude T. Tagny (a2) (a5), Emilienne Nchindap (a5), Léopoldine Kenmogne (a5), Donald Franklin (a4), Dora M. Njamnshi (a6), Dora Mbanya (a2) (a5), Alfred K. Njamnshi (a2) (a3) and Robert K. Heaton (a4)...

Abstract

Objective:

There is lack of Cameroonian adult neuropsychological (NP) norms, limited knowledge concerning HIV-associated neurocognitive disorders in Sub-Saharan Africa, and evidence of differential inflammation and disease progression based on viral subtypes. In this study, we developed demographically corrected norms and assessed HIV and viral genotypes effects on attention/working memory (WM), learning, and memory.

Method:

We administered two tests of attention/WM [Paced Auditory Serial Addition Test (PASAT)-50, Wechsler Memory Scale (WMS)-III Spatial Span] and two tests of learning and memory [Brief Visuospatial Memory Test-Revised (BVMT-R), Hopkins Verbal Learning Test-Revised (HVLT-R)] to 347 HIV+ and 395 seronegative adult Cameroonians. We assessed the effects of viral factors on neurocognitive performance.

Results:

Compared to controls, people living with HIV (PLWH) had significantly lower T-scores on PASAT-50 and attention/WM summary scores, on HVLT-R total learning and learning summary scores, on HVLT-R delayed recall, BVMT-R delayed recall and memory summary scores. More PLWH had impairment in attention/WM, learning, and memory. Antiretroviral therapy (ART) and current immune status had no effect on T-scores. Compared to untreated cases with detectable viremia, untreated cases with undetectable viremia had significantly lower (worse) T-scores on BVMT-R total learning, BVMT-R delayed recall, and memory composite scores. Compared to PLWH infected with other subtypes (41.83%), those infected with HIV-1 CRF02_AG (58.17%) had higher (better) attention/WM T-scores.

Conclusions:

PLWH in Cameroon have impaired attention/WM, learning, and memory and those infected with CRF02_AG viruses showed reduced deficits in attention/WM. The first adult normative standards for assessing attention/WM, learning, and memory described, with equations for computing demographically adjusted T-scores, will facilitate future studies of diseases affecting cognitive function in Cameroonians.

Copyright

Corresponding author

Correspondence and reprint requests to: Georgette Kanmogne, PhD, MPH, Professor, Vice-Chair for Resource Allocation and Faculty Development, Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE68198-5800, USA. E-mail: gkanmogne@unmc.edu

References

Hide All
Acharya, A., Fonsah, J.Y., Mbanya, D., Njamnshi, A.K., & Kanmogne, G.D. (2019). Near-full-length genetic characterization of a novel HIV-1 unique recombinant with similarities to A1, CRF01_AE, and CRFO2_AG viruses in Yaounde, Cameroon. AIDS Research and Human Retroviruses, 35(8), 762768.
Akolo, C., Royal, W., Cherner, M., Okwuasaba, K., Eyzaguirre, L., Adebiyi, R., Umlauf, A., Hendrix, T., Johnson, J., Abimiku, A., & Blattner, W.A. (2014). Neurocognitive impairment associated with predominantly early stage HIV infection in Abuja, Nigeria. Journal of NeuroVirology, 20(4), 380387.
Antinori, A., Arendt, G., Becker, J.T., Brew, B.J., Byrd, D.A., Cherner, M., Clifford, D.B., Cinque, P., Epstein, L.G., Goodkin, K., Gisslen, M., Grant, I., Heaton, R.K., Joseph, J., Marder, K., Marra, C.M., McArthur, J.C., Nunn, M., Price, R.W., Pulliam, L., Robertson, K.R., Sacktor, N., Valcour, V., & Wojna, V.E. (2007). Updated research nosology for HIV-associated neurocognitive disorders. Neurology, 69(18), 17891799.
Arentoft, A., Byrd, D., Monzones, J., Coulehan, K., Fuentes, A., Rosario, A., Miranda, C., Morgello, S., & Rivera Mindt, M. (2015). Socioeconomic status and neuropsychological functioning: associations in an ethnically diverse HIV+ Cohort. The Clinical Neuropsychologist, 29(2), 232254.
Ayisi, N.K. & Nyadedzor, C. (2003). Comparative in vitro effects of AZT and extracts of Ocimum gratissimum, Ficus polita, Clausena anisata, Alchornea cordifolia, and Elaeophorbia drupifera against HIV-1 and HIV-2 infections. Antiviral Research, 58(1), 2533.
Belanger, H.G., Kretzmer, T., Yoash-Gantz, R., Pickett, T., & Tupler, L.A. (2009). Cognitive sequelae of blast-related versus other mechanisms of brain trauma. Journal of the International Neuropsychological Society, 15(1), 18.
Benedict, R. (1997). Brieft Visuospatial Memory Test-revisited. Odessa, FL: Psychological Assessment Resources, Inc.
Benedict, R.H. & Zivadinov, R. (2007). Reliability and validity of neuropsychological screening and assessment strategies in MS. Journal of Neurology, 254(Suppl 2), II22II25.
Bhargavan, B. & Kanmogne, G.D. (2018). Differential mechanisms of inflammation and endothelial dysfunction by HIV-1 subtype-B and recombinant CRF02_AG Tat proteins on human brain microvascular endothelial cells: implications for viral neuropathogenesis. Molecular Neurobiology, 55(2), 13521363.
Bhargavan, B. & Kanmogne, G.D. (2019). Epigenetics, N-myrystoyltransferase-1 and casein kinase-2-alpha modulates the increased replication of HIV-1 CRF02_AG, compared to subtype-B viruses. Scientific Reports, 9(1), 10689.
Brandt, J. & Benedict, R. (2001). Hopkins Verbal Learning Test-revised. Lutz, FL: Phsychological Assessment Resources, Inc.
Brennan, C.A., Bodelle, P., Coffey, R., Devare, S.G., Golden, A., Hackett, J. Jr., Harris, B., Holzmayer, V., Luk, K.C., Schochetman, G., Swanson, P., Yamaguchi, J., Vallari, A., Ndembi, N., Ngansop, C., Makamche, F., Mbanya, D., Gurtler, L.G., Zekeng, L., & Kaptue, L. (2008). The prevalence of diverse HIV-1 strains was stable in Cameroonian blood donors from 1996 to 2004. Journal of Acquired Immune Deficiency Syndromes, 49(4), 432439.
Carey, C.L., Woods, S.P., Rippeth, J.D., Gonzalez, R., Moore, D.J., Marcotte, T.D., Grant, I., Heaton, R.K., & Group, H. (2004). Initial validation of a screening battery for the detection of HIV-associated cognitive impairment. The Clinical Neuropsychologist, 18(2), 234248.
Casaletto, K.B., Umlauf, A., Beaumont, J., Gershon, R., Slotkin, J., Akshoomoff, N., & Heaton, R.K. (2015). Demographically corrected normative standards for the English version of the NIH toolbox cognition battery. Journal of the International Neuropsychological Society, 21(5), 378391.
Cohen, R.A., Siegel, S., Gullett, J.M., Porges, E., Woods, A.J., Huang, H., Zhu, Y., Tashima, K., & Ding, M.Z. (2018). Neural response to working memory demand predicts neurocognitive deficits in HIV. Journal of NeuroVirology, 24(3), 291304.
Cowan, N. (2008). What are the differences between long-term, short-term, and working memory? Progress in Brain Research, 169, 323338.
Cysique, L.A., Heaton, R.K., Kamminga, J., Lane, T., Gates, T.M., Moore, D.M., Hubner, E., Carr, A., & Brew, B.J. (2014). HIV-associated neurocognitive disorder in Australia: a case of a high-functioning and optimally treated cohort and implications for international neuroHIV research. Journal of NeuroVirology, 20(3), 258268.
Cysique, L.A., Jin, H., Franklin, D.R. Jr., Morgan, E.E., Shi, C., Yu, X., Wu, Z., Taylor, M.J., Marcotte, T.D., Letendre, S., Ake, C., Grant, I., Heaton, R.K., & Group, H. (2007). Neurobehavioral effects of HIV-1 infection in China and the United States: a pilot study. Journal of the International Neuropsychological Society, 13(5), 781790.
de Almeida, S.M., Ribeiro, C.E., de Pereira, A.P., Badiee, J., Cherner, M., Smith, D., Maich, I., Raboni, S.M., Rotta, I., Barbosa, F.J., Heaton, R.K., Umlauf, A., & Ellis, R.J. (2013). Neurocognitive impairment in HIV-1 clade C- versus B-infected individuals in Southern Brazil. Journal of NeuroVirology, 19(6), 550556.
de Almeida, S.M., Rotta, I., Jiang, Y., Li, X., Raboni, S.M., Ribeiro, C.E., Smith, D., Potter, M., Vaida, F., Letendre, S., Ellis, R.J., & Group, H. (2016). Biomarkers of chemotaxis and inflammation in cerebrospinal fluid and serum in individuals with HIV-1 subtype C versus B. Journal of NeuroVirology, 22(6), 715724.
Diehr, M.C., Cherner, M., Wolfson, T.J., Miller, S.W., Grant, I., Heaton, R.K., & Group, H.I.V.N.R.C. (2003). The 50 and 100-item short forms of the Paced Auditory Serial Addition Task (PASAT): demographically corrected norms and comparisons with the full PASAT in normal and clinical samples. Journal of Clinical and Experimental Neuropsychology, 25(4), 571585.
Dujardin, K., Deneve, C., Ronval, M., Krystkowiak, P., Humez, C., Destee, A., & Defebvre, L. (2007). Is the paced auditory serial addition test (PASAT) a valid means of assessing executive function in Parkinson’s disease? Cortex, 43(5), 601606.
Ellis, R.J., Badiee, J., Vaida, F., Letendre, S., Heaton, R.K., Clifford, D., Collier, A.C., Gelman, B., McArthur, J., Morgello, S., McCutchan, J.A., Grant, I., & Group, C. (2011). CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS, 25(14), 17471751.
Erb, P., Battegay, M., Zimmerli, W., Rickenbach, M., & Egger, M. (2000). Effect of antiretroviral therapy on viral load, CD4 cell count, and progression to acquired immunodeficiency syndrome in a community human immunodeficiency virus-infected cohort. Swiss HIV Cohort Study. Archives of Internal Medicine, 160(8), 11341140.
Ettenhofer, M.L., Foley, J., Castellon, S.A., & Hinkin, C.H. (2010). Reciprocal prediction of medication adherence and neurocognition in HIV/AIDS. Neurology, 74(15), 12171222.
Farinpour, R., Martin, E.M., Seidenberg, M., Pitrak, D.L., Pursell, K.J., Mullane, K.M., Novak, R.M., & Harrow, M. (2000). Verbal working memory in HIV-seropositive drug users. Journal of the International Neuropsychological Society, 6(5), 548555.
Fogel, J.M., Wang, L., Parsons, T.L., Ou, S.S., Piwowar-Manning, E., Chen, Y., Mudhune, V.O., Hosseinipour, M.C., Kumwenda, J., Hakim, J.G., Chariyalertsak, S., Panchia, R., Sanne, I., Kumarasamy, N., Grinsztejn, B., Makhema, J., Pilotto, J., Santos, B.R., Mayer, K.H., McCauley, M., Gamble, T., Bumpus, N.N., Hendrix, C.W., Cohen, M.S., & Eshleman, S.H. (2013). Undisclosed antiretroviral drug use in a multinational clinical trial (HIV Prevention Trials Network 052). The Journal of Infectious Diseases, 208(10), 16241628.
Foster, P.S., Drago, V., Crucian, G.P., Skidmore, F., Rhodes, R.D., Shenal, B.V., Skoblar, B., & Heilman, K.M. (2010). Verbal and visuospatial memory in lateral onset Parkinson disease: time is of the essence. Cognitive and Behavioral Neurology, 23(1), 1925.
Gandhi, N., Saiyed, Z., Thangavel, S., Rodriguez, J., Rao, K.V., & Nair, M.P. (2009). Differential effects of HIV type 1 clade B and clade C Tat protein on expression of proinflammatory and antiinflammatory cytokines by primary monocytes. AIDS Research and Human Retroviruses, 25(7), 691699.
Garcia, F., Vidal, C., Gatell, J.M., Miro, J.M., Soriano, A., & Pumarola, T. (1997). Viral load in asymptomatic patients with CD4+ lymphocyte counts above 500 x 10(6)/l. AIDS, 11(1), 5357.
Gronwall, D.M. (1977). Paced auditory serial-addition task: a measure of recovery from concussion. Perceptual and Motor Skills, 44(2), 367373.
Gupta, J.D., Satishchandra, P., Gopukumar, K., Wilkie, F., Waldrop-Valverde, D., Ellis, R., Ownby, R., Subbakrishna, D.K., Desai, A., Kamat, A., Ravi, V., Rao, B.S., Satish, K.S., & Kumar, M. (2007). Neuropsychological deficits in human immunodeficiency virus type 1 clade C-seropositive adults from South India. Journal of NeuroVirology, 13(3), 195202.
Haile, K.T., Ayele, A.A., Mekuria, A.B., Demeke, C.A., Gebresillassie, B.M., & Erku, D.A. (2017). Traditional herbal medicine use among people living with HIV/AIDS in Gondar, Ethiopia: do their health care providers know? Complementary Therapies in Medicine, 35, 1419.
Haokip, P., Singh, H.R., Laldinmawii, G., Marak, E.K., & Roy, A. (2018). Quantification of human immunodeficiency virus-1 viral load and its correlation with CD4 cell count in antiretroviral therapy naïve patients attending Regional Institute of Medical Sciences Hospital, Imphal. Journal of Medical Society, 32(2), 89102.
Heaton, R.K., Clifford, D.B., Franklin, D.R. Jr., Woods, S.P., Ake, C., Vaida, F., Ellis, R.J., Letendre, S.L., Marcotte, T.D., Atkinson, J.H., Rivera-Mindt, M., Vigil, O.R., Taylor, M.J., Collier, A.C., Marra, C.M., Gelman, B.B., McArthur, J.C., Morgello, S., Simpson, D.M., McCutchan, J.A., Abramson, I., Gamst, A., Fennema-Notestine, C., Jernigan, T.L., Wong, J., Grant, I., & Group, C. (2010). HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology, 75(23), 20872096.
Heaton, R.K., Franklin, D.R. Jr., Deutsch, R., Letendre, S., Ellis, R.J., Casaletto, K., Marquine, M.J., Woods, S.P., Vaida, F., Atkinson, J.H., Marcotte, T.D., McCutchan, J.A., Collier, A.C., Marra, C.M., Clifford, D.B., Gelman, B.B., Sacktor, N., Morgello, S., Simpson, D.M., Abramson, I., Gamst, A.C., Fennema-Notestine, C., Smith, D.M., Grant, I., & Group, C. (2015). Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study. Clinical Infectious Diseases, 60(3), 473480.
Heaton, R.K., Marcotte, T.D., Mindt, M.R., Sadek, J., Moore, D.J., Bentley, H., McCutchan, J.A., Reicks, C., Grant, I., & Group, H. (2004). The impact of HIV-associated neuropsychological impairment on everyday functioning. Journal of the International Neuropsychological Society, 10(3), 317331.
Helfer, M., Koppensteiner, H., Schneider, M., Rebensburg, S., Forcisi, S., Muller, C., Schmitt-Kopplin, P., Schindler, M., & Brack-Werner, R. (2014). The root extract of the medicinal plant Pelargonium sidoides is a potent HIV-1 attachment inhibitor. PLoS One, 9(1), e87487.
Hestad, K.A., Chinyama, J., Anitha, M.J., Ngoma, M.S., McCutchan, J.A., Franklin, D.R. Jr., & Heaton, R.K. (2019). Cognitive impairment in Zambians with HIV infection and pulmonary tuberculosis. Journal of Acquired Immune Deficiency Syndromes, 80(1), 110117.
Hoare, J., Fouche, J.P., Spottiswoode, B., Sorsdahl, K., Combrinck, M., Stein, D.J., Paul, R.H., & Joska, J.A. (2011). White-Matter damage in Clade C HIV-positive subjects: a diffusion tensor imaging study. The Journal of Neuropsychiatry and Clinical Neurosciences, 23(3), 308315.
Hong, S. & Banks, W.A. (2015). Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications. Brain, Behavior, and Immunity, 45, 112.
IndexMundi. (2018). Cameroon Demographics Profile 2018. World Fackbook, https://www.indexmundi.com/cameroon/demographics_profile.html.
Joska, J.A., Fincham, D.S., Stein, D.J., Paul, R.H., & Seedat, S. (2010). Clinical correlates of HIV-associated neurocognitive disorders in South Africa. AIDS Behaviour, 14(2), 371378.
Joska, J.A., Westgarth-Taylor, J., Myer, L., Hoare, J., Thomas, K.G., Combrinck, M., Paul, R.H., Stein, D.J., & Flisher, A.J. (2011). Characterization of HIV-associated neurocognitive disorders among individuals starting antiretroviral therapy in South Africa. AIDS Behaviour, 15(6), 11971203.
Jumare, J., El-Kamary, S.S., Magder, L., Hungerford, L., Umlauf, A., Franklin, D., Ghate, M., Abimiku, A., Charurat, M., Letendre, S., Ellis, R.J., Mehendale, S., Blattner, W.A., Royal, W., Marcotte, T.D., Heaton, R.K., Grant, I., & McCutchan, J.A. (2019). Brief report: body mass index and cognitive function among HIV-1-infected individuals in China, India, and Nigeria. Journal of Acquired Immune Deficiency Syndromes, 80(2), e30e35.
Jumare, J., Ndembi, N., El-Kamary, S.S., Magder, L., Hungerford, L., Burdo, T., Eyzaguirre, L.M., Dakum, P., Umlauf, A., Cherner, M., Abimiku, A., Charurat, M., Blattner, W.A., & Royal, W.. (2018). Cognitive function among antiretroviral treatment-naive individuals infected with HIV-1 Subtype G versus CRF02_AG in Nigeria. Clinical Infectious Diseases, 66(9), 14481453.
Kabuba, N., Anitha Menon, J., Franklin, D.R. Jr., Heaton, R.K., & Hestad, K.A. (2017). Use of Western Neuropsychological Test Battery in Detecting HIV-Associated Neurocognitive Disorders (HAND) in Zambia. AIDS Behaviour, 21(6), 17171727.
Kahle, E.M., Kashuba, A., Baeten, J.M., Fife, K.H., Celum, C., Mujugira, A., Essex, M., De Bruyn, G., Wald, A., Donnell, D., John-Stewart, G., Delany-Moretlwe, S., Mugo, N.R., Farquhar, C., Lingappa, J.R., & Partners in Prevention, H.T.S.T. (2014). Unreported antiretroviral use by HIV-1-infected participants enrolling in a prospective research study. Journal of Acquired Immune Deficiency Syndromes, 65(2), e90e94.
Kamat, R., McCutchan, A., Kumarasamy, N., Marcotte, T.D., Umlauf, A., Selvamuthu, P., Meyer, R., Letendre, S., Heaton, R., & Bharti, A.R. (2017). Neurocognitive functioning among HIV-positive adults in southern India. Journal of NeuroVirology, 23(5), 750755.
Kanmogne, G.D., Fonsah, J.Y., Tang, B., Doh, R.F., Kengne, A.M., Umlauf, A., Tagny, C.T., Nchindap, E., Kenmogne, L., Franklin, D., Njamnshi, D.M., Mbanya, D., Njamnshi, A.K., & Heaton, R.K. (2018). Effects of HIV on executive function and verbal fluency in Cameroon. Scientific Reports, 8(1), 17794.
Kanmogne, G.D., Kuate, C.T., Cysique, L.A., Fonsah, J.Y., Eta, S., Doh, R., Njamnshi, D.M., Nchindap, E., Franklin, D.R. Jr., Ellis, R.J., McCutchan, J.A., Binam, F., Mbanya, D., Heaton, R.K., & Njamnshi, A.K. (2010). HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon. BMC Neurology, 10, 60.
Kennedy, A., Petrasca, A., Doherty, D.G., Hennessy, M., & Spiers, J.P. (2014). HIV-1 Tat clade-specific cytokine induction in monocytes/macrophages is not evidenced in total or Vgamma9Vdelta2 T lymphocytes. AIDS, 28(1), 131133.
Kujala, P., Portin, R., Revonsuo, A., & Ruutiainen, J. (1995). Attention related performance in two cognitively different subgroups of patients with multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry, 59(1), 7782.
Kumar, A.M., Ownby, R.L., Waldrop-Valverde, D., Fernandez, B., & Kumar, M. (2011). Human immunodeficiency virus infection in the CNS and decreased dopamine availability: relationship with neuropsychological performance. Journal of NeuroVirology, 17(1), 2640.
LANL. (2017). HIV and SIV Nomenclature. HIV sequence database. https://www.hiv.lanl.gov/content/sequence/HelpDocs/subtypes-more.html.
LANL. (2019). HIV Circulating Recombinant Forms (CRFs). HIV sequence database. http://www.hiv.lanl.gov/content/sequence/HIV/CRFs/CRFs.html.
Lawler, K., Jeremiah, K., Mosepele, M., Ratcliffe, S.J., Cherry, C., Seloilwe, E., & Steenhoff, A.P. (2011). Neurobehavioral effects in HIV-positive individuals receiving highly active antiretroviral therapy (HAART) in Gaborone, Botswana. PLoS One, 6(2), e17233.
Lawler, K., Mosepele, M., Ratcliffe, S., Seloilwe, E., Steele, K., Nthobatsang, R., & Steenhoff, A. (2010). Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study. Journal of the International AIDS Society, 13, 15.
Leteane, M.M., Ngwenya, B.N., Muzila, M., Namushe, A., Mwinga, J., Musonda, R., Moyo, S., Mengestu, Y.B., Abegaz, B.M., & Andrae-Marobela, K. (2012). Old plants newly discovered: Cassia sieberiana D.C. and Cassia abbreviata Oliv. Oliv. root extracts inhibit in vitro HIV-1c replication in peripheral blood mononuclear cells (PBMCs) by different modes of action. Journal of Ethnopharmacology, 141(1), 4856.
Levine, A.J., Hinkin, C.H., Castellon, S.A., Mason, K.I., Lam, M.N., Perkins, A., Robinet, M., Longshore, D., Newton, T., Myers, H., Durvasula, R.S., & Hardy, D.J. (2005). Variations in patterns of highly active antiretroviral therapy (HAART) adherence. AIDS Behaviour, 9(3), 355362.
Lihana, R.W., Ssemwanga, D., Abimiku, A., & Ndembi, N. (2012). Update on HIV-1 diversity in Africa: a decade in review. AIDS Reviews, 14(2), 83100.
Mabou Tagne, A., Biapa Nya, P.C., Tiotsia Tsapi, A., Edingue Essoh, A.K., Pembouong, G., Ngouadjeu Ngnintedem, M.A., Marino, F., & Cosentino, M. (2019). Determinants, prevalence and trend of use of medicinal plants among people living with HIV: a cross-sectional survey in Dschang, Cameroon. AIDS Behaviour, 23(8), 20882100.
Maki, P.M., Rubin, L.H., Valcour, V., Martin, E., Crystal, H., Young, M., Weber, K.M., Manly, J., Richardson, J., Alden, C., & Anastos, K. (2015). Cognitive function in women with HIV: findings from the Women’s Interagency HIV Study. Neurology, 84(3), 231240.
Malagurski, B., Bugarski Ignjatovic, V., Maric, D., Nikolasevic, Z., Mihic, L., & Brkic, S. (2018). Neurocognitive profile of HIV-positive adults on combined antiretroviral therapy: a single-centre study in Serbia. Applied Neuropsychology: Adult, 25(6), 513522.
Martin, E.M., Sullivan, T.S., Reed, R.A., Fletcher, T.A., Pitrak, D.L., Weddington, W., & Harrow, M. (2001). Auditory working memory in HIV-1 infection. Journal of the International Neuropsychological Society, 7(1), 2026.
Martinson, N.A., Gupte, N., Msandiwa, R., Moulton, L.H., Barnes, G.L., Ram, M., Gray, G., Hoffmann, C., & Chaisson, R.E. (2014). CD4 and viral load dynamics in antiretroviral-naive HIV-infected adults from Soweto, South Africa: a prospective cohort. PLoS One, 9(5), e96369.
Marzinke, M.A., Clarke, W., Wang, L., Cummings, V., Liu, T.Y., Piwowar-Manning, E., Breaud, A., Griffith, S., Buchbinder, S., Shoptaw, S., del Rio, C., Magnus, M., Mannheimer, S., Fields, S.D., Mayer, K.H., Wheeler, D.P., Koblin, B.A., Eshleman, S.H., & Fogel, J.M. (2014). Nondisclosure of HIV status in a clinical trial setting: antiretroviral drug screening can help distinguish between newly diagnosed and previously diagnosed HIV infection. Clinical Infectious Diseases, 58(1), 117120.
Mbaveng, A.T., Kuete, V., Mapunya, B.M., Beng, V.P., Nkengfack, A.E., Meyer, J.J., & Lall, N. (2011). Evaluation of four Cameroonian medicinal plants for anticancer, antigonorrheal and antireverse transcriptase activities. Environmental Toxicology and Pharmacology, 32(2), 162167.
Mindel, A. & Tenant-Flowers, M. (2001). ABC of AIDS: natural history and management of early HIV infection. BMJ, 322(7297), 12901293.
Mogambery, J.C., Dawood, H., Wilson, D., & Moodley, A. (2017). HIV-associated neurocognitive disorder in a KwaZulu-Natal HIV clinic: a prospective study. Southern African Journal of HIV Medicine, 18(1), 732.
Morgan, E.E., Woods, S.P., Weber, E., Dawson, M.S., Carey, C.L., Moran, L.M., Grant, I., & Group, H.I.V.N.R.C. (2009). HIV-associated episodic memory impairment: evidence of a possible differential deficit in source memory for complex visual stimuli. The Journal of Neuropsychiatry and Clinical Neurosciences, 21(2), 189198.
Nakku, J., Kinyanda, E., & Hoskins, S. (2013). Prevalence and factors associated with probable HIV dementia in an African population: a cross-sectional study of an HIV/AIDS clinic population. BMC Psychiatry, 13, 126.
Nichols, S.L., Bethel, J., Kapogiannis, B.G., Li, T., Woods, S.P., Patton, E.D., Ren, W., Thornton, S.E., Major-Wilson, H.O., Puga, A.M., Sleasman, J.W., Rudy, B.J., Wilson, C.M., Garvie, P.A., & Adolescent Medicine Trials Network for, H.I.V.A.I. (2016). Antiretroviral treatment initiation does not differentially alter neurocognitive functioning over time in youth with behaviorally acquired HIV. Journal of NeuroVirology, 22(2), 218230.
Njamnshi, A.K., Bissek, A.C., Ongolo-Zogo, P., Tabah, E.N., Lekoubou, A.Z., Yepnjio, F.N., Fonsah, J.Y., Kuate, C.T., Angwafor, S.A., Dema, F., Njamnshi, D.M., Kouanfack, C., Djientcheu Vde, P., Muna, W.F., & Kanmogne, G.D. (2009). Risk factors for HIV-associated neurocognitive disorders (HAND) in sub-Saharan Africa: the case of Yaounde-Cameroon. Journal of the Neurological Sciences, 285(1–2), 149153.
Njamnshi, A.K., Djientcheu Vde, P., Fonsah, J.Y., Yepnjio, F.N., Njamnshi, D.M., & Muna, W.E. (2008). The International HIV Dementia Scale is a useful screening tool for HIV-associated dementia/cognitive impairment in HIV-infected adults in Yaounde-Cameroon. Journal of Acquired Immune Deficiency Syndromes, 49(4), 393397.
O’Jile, J.R., Ryan, L.M., Betz, B., Parks-Levy, J., Hilsabeck, R.C., Rhudy, J.L., & Gouvier, W.D. (2006). Information processing following mild head injury. Archives of Clinical Neuropsychology, 21(4), 293296.
Obermeit, L.C., Morgan, E.E., Casaletto, K.B., Grant, I., Woods, S.P., & Group, H.I.V.N.R.P. (2015). Antiretroviral non-adherence is associated with a retrieval profile of deficits in verbal episodic memory. The Clinical Neuropsychologist, 29(2), 197213.
Odaibo, G.N., Adewole, I.F., & Olaleye, D.O. (2013). High rate of non-detectable HIV-1 RNA among antiretroviral drug naive HIV positive individuals in Nigeria. Virology (Auckl), 4, 3540.
Ortega, M., Heaps, J.M., Joska, J., Vaida, F., Seedat, S., Stein, D.J., Paul, R., & Ances, B.M. (2013). HIV clades B and C are associated with reduced brain volumetrics. Journal of NeuroVirology, 19(5), 479487.
Paul, R.H., Phillips, S., Hoare, J., Laidlaw, D.H., Cabeen, R., Olbricht, G.R., Su, Y., Stein, D.J., Engelbrecht, S., Seedat, S., Salminen, L.E., Baker, L.M., Heaps, J., & Joska, J. (2017). Neuroimaging abnormalities in clade C HIV are independent of Tat genetic diversity. Journal of NeuroVirology, 23(2), 319328.
Prevey, M.L., Delaney, R.C., Cramer, J.A., & Mattson, R.H. (1998). Complex partial and secondarily generalized seizure patients: cognitive functioning prior to treatment with antiepileptic medication. VA Epilepsy Cooperative Study 264 Group. Epilepsy Research, 30(1), 19.
Ranga, U., Shankarappa, R., Siddappa, N.B., Ramakrishna, L., Nagendran, R., Mahalingam, M., Mahadevan, A., Jayasuryan, N., Satishchandra, P., Shankar, S.K., & Prasad, V.R. (2004). Tat protein of human immunodeficiency virus type 1 subtype C strains is a defective chemokine. Journal of Virology, 78(5), 25862590.
Rao, V.R., Neogi, U., Talboom, J.S., Padilla, L., Rahman, M., Fritz-French, C., Gonzalez-Ramirez, S., Verma, A., Wood, C., Ruprecht, R.M., Ranga, U., Azim, T., Joska, J., Eugenin, E., Shet, A., Bimonte-Nelson, H., Tyor, W.R., & Prasad, V.R. (2013). Clade C HIV-1 isolates circulating in Southern Africa exhibit a greater frequency of dicysteine motif-containing Tat variants than those in Southeast Asia and cause increased neurovirulence. Retrovirology, 10, 61.
Rao, V.R., Sas, A.R., Eugenin, E.A., Siddappa, N.B., Bimonte-Nelson, H., Berman, J.W., Ranga, U., Tyor, W.R., & Prasad, V.R. (2008). HIV-1 clade-specific differences in the induction of neuropathogenesis. Journal of Neuroscience, 28(40), 1001010016.
Reger, M., Welsh, R., Razani, J., Martin, D.J., & Boone, K.B. (2002). A meta-analysis of the neuropsychological sequelae of HIV infection. Journal of the International Neuropsychological Society, 8(3), 410424.
Rieu, D., Bachoud-Levi, A.C., Laurent, A., Jurion, E., & Dalla Barba, G. (2006). French adaptation of the Hopkins Verbal Learning Test. Revue Neurologique (Paris), 162(6–7), 721728.
Robertson, D.L., Anderson, J.P., Bradac, JA, Carr, JK, Foley, B, Funkhouser, R.K., Gao, F., Hahn, B.H., Kalish, M.L., Kuiken, C., Learn, G.H., Leitner, T., McCutchan, F., Osmanov, S., Peeters, M., Pieniazek, D., Salminen, M., Sharp, P.M., Wolinsky, S., & Korber, B. (2000). HIV-1 nomenclature proposal. Science, 288, 5556.
Robertson, K., Jiang, H., Evans, S.R., Marra, C.M., Berzins, B., Hakim, J., Sacktor, N., Silva, M.T., Campbell, T.B., Nair, A., Schouten, J., Kumwenda, J., Supparatpinyo, K., Tripathy, S., Kumarasamy, N., la Rosa, A., Montano, S., Mwafongo, A., Firnhaber, C., Sanne, I., Naini, L., Amod, F., Walawander, A., & Group, A.C.T. (2016). International neurocognitive normative study: neurocognitive comparison data in diverse resource-limited settings: AIDS Clinical Trials Group A5271. Journal of NeuroVirology, 22(4), 472478.
Robertson, K., Maruff, P., Ross, L.L., Wohl, D., Small, C.B., Edelstein, H., & Shaefer, M.S. (2019). Similar neurocognitive outcomes after 48 weeks in HIV-1-infected participants randomized to continue tenofovir/emtricitabine + atazanavir/ritonavir or simplify to abacavir/lamivudine + atazanavir. Journal of NeuroVirology, 25(1), 2231.
Robertson, K.R., Nakasujja, N., Wong, M., Musisi, S., Katabira, E., Parsons, T.D., Ronald, A., & Sacktor, N. (2007). Pattern of neuropsychological performance among HIV positive patients in Uganda. BMC Neurology, 7, 8.
Robertson, K.R., Smurzynski, M., Parsons, T.D., Wu, K., Bosch, R.J., Wu, J., McArthur, J.C., Collier, A.C., Evans, S.R., & Ellis, R.J. (2007). The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS, 21(14), 19151921.
Royal, W., Cherner, M., Carr, J., Habib, A.G., Akomolafe, A., Abimiku, A., Charurat, M., Farley, J., Oluyemisi, A., Mamadu, I., Johnson, J., Ellis, R., McCutchan, J.A., Grant, I., & Blattner, W.A. (2012). Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria. Journal of NeuroVirology, 18(3), 191199.
Royston, P. & Altman, D.G. (1994). Regression using fractional polynomials of continuous covariates: parsimonious parametric modelling. Applied Statistics, 43(3), 429467.
Rubin, L.H., Cook, J.A., Weber, K.M., Cohen, M.H., Martin, E., Valcour, V., Milam, J., Anastos, K., Young, M.A., Alden, C., Gustafson, D.R., & Maki, P.M. (2015). The association of perceived stress and verbal memory is greater in HIV-infected versus HIV-uninfected women. Journal of NeuroVirology, 21(4), 422432.
Rubin, L.H., Maki, P.M., Springer, G., Benning, L., Anastos, K., Gustafson, D., Villacres, M.C., Jiang, X., Adimora, A.A., Waldrop-Valverde, D., Vance, D.E., Bolivar, H., Alden, C., Martin, E.M., Valcour, V.G., & Women’s Interagency, H.I.V.S. (2017). Cognitive trajectories over 4 years among HIV-infected women with optimal viral suppression. Neurology, 89(15), 15941603.
Sabin, C.A. & Lundgren, J.D. (2013). The natural history of HIV infection. Current Opinion in HIV and AIDS, 8(4), 311317.
Sacktor, N., Saylor, D., Nakigozi, G., Nakasujja, N., Robertson, K., Grabowski, M.K., Kisakye, A., Batte, J., Mayanja, R., Anok, A., Gray, R.H., & Wawer, M.J. (2019). Effect of HIV subtype and antiretroviral therapy on HIV-associated neurocognitive disorder stage in Rakai, Uganda. Journal of Acquired Immune Deficiency Syndromes, 81(2), 216223.
Salawu, F.K., Bwala, S.A., Wakil, M.A., Bani, B., Bukbuk, D.N., & Kida, I. (2008). Cognitive function in HIV-seropositive Nigerians without AIDS. Journal of Neurology Science, 267(1–2), 142146.
Saloner, R. & Cysique, L.A. (2017). HIV-associated neurocognitive disorders: a global perspective. Journal of the International Neuropsychological Society, 23(9–10), 860869.
Satishchandra, P., Nalini, A., Gourie-Devi, M., Khanna, N., Santosh, V., Ravi, V., Desai, A., Chandramuki, A., Jayakumar, P.N., & Shankar, S.K. (2000). Profile of neurologic disorders associated with HIV/AIDS from Bangalore, south India (198996). Indian Journal of Medical Research, 111, 1423.
Spies, G., Fennema-Notestine, C., Archibald, S.L., Cherner, M., & Seedat, S. (2012). Neurocognitive deficits in HIV-infected women and victims of childhood trauma. AIDS Care, 24(9), 11261135.
Sullivan, A.K., Savage, E.J., Lowndes, C.M., Paul, G., Murphy, G., Carne, S., Back, D.J., & Gill, O.N. (2013). Non-disclosure of HIV status in UK sexual health clinics -- a pilot study to identify non-disclosure within a national unlinked anonymous seroprevalence survey. Sexually Transmitted Infections, 89(2), 120121.
Teto, G., Fonsah, J.Y., Tagny, C.T., Mbanya, D., Nchindap, E., Kenmogne, L., Fokam, J., Njamnshi, D.M., Kouanfack, C., Njamnshi, A.K., & Kanmogne, G.D. (2016). Molecular and genetic characterization of HIV-1 Tat Exon-1 gene from Cameroon shows conserved Tat HLA-binding epitopes: functional implications. Viruses, 8(7), 196.
Teto, G., Tagny, C.T., Mbanya, D., Fonsah, J.Y., Fokam, J., Nchindap, E., Kenmogne, L., Njamnshi, A.K., & Kanmogne, G.D. (2017). Gag P2/NC and pol genetic diversity, polymorphism, and drug resistance mutations in HIV-1 CRF02_AG- and non-CRF02_AG-infected patients in Yaounde, Cameroon. Scientific Reports, 7(1), 14136.
Tietjen, I., Ntie-Kang, F., Mwimanzi, P., Onguene, P.A., Scull, M.A., Idowu, T.O., Ogundaini, A.O., Meva’a, L.M., Abegaz, B.M., Rice, C.M., Andrae-Marobela, K., Brockman, M.A., Brumme, Z.L., & Fedida, D. (2015). Screening of the Pan-African natural product library identifies ixoratannin A-2 and boldine as novel HIV-1 inhibitors. PLoS One, 10(4), e0121099.
Tilghman, M.W., Bhattacharya, J., Deshpande, S., Ghate, M., Espitia, S., Grant, I., Marcotte, T.D., Smith, D., & Mehendale, S. (2014). Genetic attributes of blood-derived subtype-C HIV-1 tat and env in India and neurocognitive function. Journal of Medical Virology, 86(1), 8896.
UNAIDS. (2016). Country factsheets: CAMEROON 2016 HIV and AIDS estimates. http://www.unaids.org/en/regionscountries/countries/cameroon/.
Valcour, V., Yee, P., Williams, A.E., Shiramizu, B., Watters, M., Selnes, O., Paul, R., Shikuma, C., & Sacktor, N. (2006). Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection -- The Hawaii Aging with HIV Cohort. Journal of NeuroVirology, 12(5), 387391.
Venner, C.M., Nankya, I., Kyeyune, F., Demers, K., Kwok, C., Chen, P.L., Rwambuya, S., Munjoma, M., Chipato, T., Byamugisha, J., Van Der Pol, B., Mugyenyi, P., Salata, R.A., Morrison, C.S., & Arts, E.J. (2016). Infecting HIV-1 subtype predicts disease progression in women of sub-Saharan Africa. EBioMedicine, 13, 305314.
Wang, M., Wang, Q., Ding, H., & Shang, H. (2015). Association of hippocampal magnetic resonance imaging with learning and memory deficits in HIV-1-seropositive patients. Journal of Acquired Immune Deficiency Syndromes, 70(4), 436443.
Wechsler, D. (1997). Wechsler Memory Scale – Third Edition. San Antonio, TX: The Psychological Corporation.
WHO. (2016). Global Health Sector Strategy on HIV 2016-2021: Towards Ending AIDS. World Health Organization, http://apps.who.int/iris/bitstream/handle/10665/246178/WHO-HIV-2016.05-eng.pdf;jsessionid=6624B3EED4E6186B44D2FB1ABA95A1A3?sequence=1.
Wilde, N.J., Strauss, E., & Tulsky, D.S. (2004). Memory span on the Wechsler Scales. Journal of Clinical and Experimental Neuropsychology, 26(4), 539549.
Woods, S.P., Moore, D.J., Weber, E., & Grant, I. (2009). Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychology Review, 19(2), 152168.
Woods, S.P., Scott, J.C., Dawson, M.S., Morgan, E.E., Carey, C.L., Heaton, R.K., Grant, I., & Group, H.I.V.N.R.C. (2005). Construct validity of Hopkins Verbal Learning Test-revised component process measures in an HIV-1 sample. Archives of Clinical Neuropsychology, 20(8), 10611071.
Woollard, S.M., Bhargavan, B., Yu, F., & Kanmogne, G.D. (2014). Differential effects of Tat proteins derived from HIV-1 subtypes B and recombinant CRF02_AG on human brain microvascular endothelial cells: implications for blood-brain barrier dysfunction. Journal of Cerebral Blood Flow & Metabolism, 34(6), 10471059.
Yang, B., Akhter, S., Chaudhuri, A., & Kanmogne, G.D. (2009). HIV-1 gp120 induces cytokine expression, leukocyte adhesion, and transmigration across the blood-brain barrier: modulatory effects of STAT1 signaling. Microvascular Research, 77(2), 212219.
Yechoor, N., Towe, S.L., Robertson, K.R., Westreich, D., Nakasujja, N., & Meade, C.S. (2016). Utility of a brief computerized battery to assess HIV-associated neurocognitive impairment in a resource-limited setting. Journal of NeuroVirology, 22(6), 808815.
Yndart, A., Kaushik, A., Agudelo, M., Raymond, A., Atluri, V.S., Saxena, S.K., & Nair, M. (2015). Investigation of neuropathogenesis in HIV-1 Clade B and C infection associated with IL-33 and ST2 regulation. ACS Chemical Neuroscience, 6(9), 16001612.
Yusuf, A.J., Hassan, A., Mamman, A.I., Muktar, H.M., Suleiman, A.M., & Baiyewu, O. (2017). Prevalence of HIV-Associated Neurocognitive Disorder (HAND) among patients attending a tertiary health facility in Northern Nigeria. Journal of the International Association of Providers of AIDS Care, 16(1), 4855.

Keywords

Related content

Powered by UNSILO

Attention/Working Memory, Learning and Memory in Adult Cameroonians: Normative Data, Effects of HIV Infection and Viral Genotype

  • Georgette D. Kanmogne (a1), Julius Y. Fonsah (a2) (a3), Anya Umlauf (a4), Jacob Moul (a4), Roland F. Doh (a3), Anne M. Kengne (a3), Bin Tang (a4), Claude T. Tagny (a2) (a5), Emilienne Nchindap (a5), Léopoldine Kenmogne (a5), Donald Franklin (a4), Dora M. Njamnshi (a6), Dora Mbanya (a2) (a5), Alfred K. Njamnshi (a2) (a3) and Robert K. Heaton (a4)...

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.